LUPUS CONDENSED



SYSTEMIC LUPUS ERYTHEMATOSUS
DISCOID LUPUS ERYTHEMATOSUS
PHOTOSENSITIVITY
RENAL LUPUS
CNS LUPUS
SUB-ACUTE CUTANEOUS LUPUS
ANA NEGATIVE LUPUS Dx
DRUG INDUCED LUPUS
RAYNAUDs PHENOMENA
SJOGRENs SYNDROME
PREGNANCY
NEONATAL LUPUS
VASCULITIS

SYSTEMIC LUPUS ERYTHEMATOSUS

Lupus also known as SLE,  can affect all parts of the body through inflammation of the connective tissues, also known as collagen.

The immune system normally makes antibodies to protect against viruses and bacteria.
In an autoimmune disorder such as lupus, the immune system loses its ability to tell the difference between bacteria and its own cells and tissues.
The immune system then makes antibodies directed against itself.
These so-called auto-antibodies react with 'self antigens' to form immune complexes, which build up in the tissues and cause inflammation, injury to tissues, and pain.

Lupus can affect all or any part of the body, including the joints, skin, kidneys, heart, lungs, blood vessels, and brain.

Although people with the disease may have many different symptoms, some of the most common ones include:

  • extreme fatigue

  • painful or swollen joints (arthritis)

  • unexplained fever and/or weight loss

  • skin rashes

  • kidney problems

Arthritis in lupus commonly affects the knees, wrists and fingers with Osteoporosis being a frequent complication of the disease and its therapy.
ie: Spinal osteoporosis may be attributable to steroids.

Lupus is also known as a rheumatic illness.

The rheumatic diseases are a group of disorders that cause aches, pain, and stiffness in the joints, muscles, and bones At present, there is no cure for lupus.
However, the symptoms of lupus can be controlled with appropriate treatment, and most people with the disease can and do lead active, healthy lifestyles with normal life spans.

Intense research is underway and scientists are continuing to make great strides in understanding lupus which may ultimately, lead to a cure.

BACK

RENAL LUPUS

Urinary, or functional renal abnormality directly related to the activity of lupus, occurs in about half of SLE patients.

Almost all lupus patients have some degree of renal involvement related to their condition, but a considerably smaller proportion of these patients actually progress to end-stage renal disease .

Lupus patients, like the rest of the population, are also susceptible to other primary renal insults that may significantly contribute to the deterioration in their renal function.

Inflammation of the kidneys (lupus nephritis) can impair their ability to effectively get rid of waste products and other toxins from the body.
This inflammation can be infectious or noninfectious and is treated accordingly by the primary care physician.
There is usually no pain associated with kidney involvement, although some patients may notice fluid retention peripherally and around the facial areas.
Most often the only indications of kidney disease is abnormal urine tests (protein, creatnine and urea results), high blood pressure and possibly high cholesterol as well as fatigue.
Urinary abnormalities occurring are regularly monitored and treated when necessary.


BACK

CNS LUPUS

CNS involvement is significantly associated with the antiphospholipid syndrome (APS).
Common symptoms of CNS lupus are:

  • Headaches

  • Memory disturbances

  • Dizziness

  • Vision problems

Some of these symptoms, however, also can be caused by some treatments of lupus or by the emotional stress of dealing with the disease.
Headaches are frequent, and their organic cause is suggested by their onset which may include sudden development and associated double vision, a migraine intensity and possibly a personality change.
Peripheral neuropathy occurs in about 10% of patients, and can involve the cranial nerves and multiple individual nerves.
Neuropsychiatric Lupus, the more acceptable medical term for cns lupus symptoms, can also include depression, anxiety and psychotic behaviour as symptomatic of the illness.

BACK


SUBACUTE CUTANEOUS LUPUS

  • This clinically distinct form of cutaneous LE has been analyzed as a separate entity and thus, its clinical importance has been more appreciated as a subset of SLE.

  • These patients frequently have a mild systemic illness marked by musculoskeletal complaints and serologic abnormalities.

  • Patients have in common a recurring, superficial, nonscarring type of cutaneous lupus erythematosus (LE) that occurrs in a characteristic distribution.

  • SCLE is usually diagnosed through a combination of signs and/or symptoms.

  • As with SLE, there really is no one symptom/sign that is absolutely diagnostic.

  • The bloodwork, the way the rash looks, the character of the rash, the pathology of the rash, systemic symptoms, etc. are all taken into consideration.

  • As SCLE rash can be itchy or not, scarring in some instances, psoriasis-like it is most usually affected by UV radiation and a report on an SCLE rash would reflect inflammation.

  • It is a rash seen in about 9% of lupus patients; 20% with SCLE also have lesions typical of discoid lupus. SCLE doesn't scar the skin, & the lesions may itch.

  • Cutaneous vasculitis is a common occurrance with SCLE.

  • SCLE is treated using antimalarials, steroids, cytotoxic drugs, sunprotection, & cortisone creams.
    BACK


ANA NEGATIVE LUPUS

  • A high incidence of both photosensitive and cutaneous involvement.

  • Arthritis and Raynaud's phenomena are common.

  • There is a low frequency of both renal and CNS involvement.

  • Many patients have a positive rheumatoid factor.

  • Prognosis is better than that given to patients who are diagnosed with positive ANAs.

    BACK

DRUG INDUCED LUPUS

A drug-induced lupus-like syndrome is characterized by mild manifestation of the following symptoms:

  • Arthralgias

  • Myalgias

  • Fever

  • Serositis

  • Pleurisy

  • Pericarditis

    CNS and renal disease are rare with drug-induced lupus.
    All symptoms will subside upon discontinuation of the medications responsible
    .


    BACK

DISCOID LUPUS ERYTHEMATOSUS

Discoid lupus erythematosus which primarily affects the skin is manifested as a red, sometimes raised rash, which may become thick and scaly, and can appear on the face, scalp or torso.
The rash may last for days or years and may undergo remissions with recurrence.
A small percentage of discoid lupus patients develope systemic involvement or SLE.
Alopecia is common with discoid lupus.

When photosensitivity is involved, a dermatologist usually provides aggressive treatment in order to prevent permanent scarring and extensive lesions.
Many patients with discoid lupus have no other systemic involvement and the prognosis leaves the patients living good quality lives over normal life spans.


BACK

PHOTOSENSITIVITY

Sun screens are effective against UVA and UVB although complete avoidance of the sun is the best course.
When a patient has discoid involvment caused by the sun, topical steroids are one of the common therapies used.
Antimalarials which have sunblocking anti-inflammatory and immunosuppressive effects are the usual prescribed treatment.
If more vigorous treatment is required, low dosage steroids or cytotoxic drugs are tried.

BACK

SJOGREN'S SYNDROME

Extreme dryness of mucosal areas and usually determined through a positive Schirmers/litmus test with an opthamologist during a regular eye exam which with Sjogrens Syndrome should be every 6-9 months..

In Sjogren's syndrome, the body's immune system mistakes its own moisture producing glands for foreign invaders.

The immune system then attacks and destroys these glands causing the typical symptoms of dry eyes and dry mouth.
This syndrome can mimic other diseases as well as occuring in a cross-over diagnosis as secondary to another primary autoimmune illness such as lupus, thereby making diagnosis difficult much like with lupus.
In addition to affecting the eyes and mouth, it can cause skin, nose and vaginal dryness and can affect the other organs of the body, including kidneys, blood vessels, lungs, liver, pancreas and brain.

There are many treatments available to treat Sjogren's Syndrome including corticosteroids and artificial tear and saliva products, both oral and systemic.
Also there are punctal plugs for dry eyes which can be inserted in the eye specialist's office and are successful by retaining any fluid you put into your eyes such as artificial tears. There are 4 punctum ducts, 2 upper and 2 lower which can be plugged. It can be a temporary or permanent treatment depending on the results as determined by the patient.

Like lupus, stress is a triggering factor for activity or flaring of the illness.
Photosensitivity can be a problem as it is in lupus, and the sun should be avoided as much as possible within reason.
The majority of sjogren patients are again, as in lupus, women.
Cause and cure of the disease is still unknown, to date.


BACK

RAYNAUD'S PHENOMENA

  • Raynaud&rsquos phenomenon can be associated with a number of conditions that feature arthritis including:

    • Scleroderma

    • Rheumatoid Arthritis (RA)

    • Systemic Lupus Erythematosus (SLE)

    • Mixed Connective Tissue Disease (MCTD)

    • Polymyositis

  • Raynaud&rsquos phenomenon is a condition that results in the discoloration of the fingers and/or the toes when the patient is exposed to changes in temperature (cold or hot) or emotional events.

  • Skin discoloration occurs because an abnormal spasm of the blood vessels results in a diminished blood supply.

  • Initially, the fingers involved turn white because of diminished blood supply.

  • The fingers then turn blue because of prolonged lack of oxygen.

  • Finally, the blood vessels reopen, causing a local flushing phenomenon, which turns the fingers red.

  • This three-phase color sequence (white to blue to red), which occurs most often upon exposure to cold temperature, is characteristic of Raynaud&rsquos phenomenon.

  • Persons with Raynaud&rsquos phenomenon should minimize their exposure to extremes of temperature (particularly cold) and rapid changes of temperature.

    BACK

PREGNANCY WITH LUPUS

Currently, 50% of all lupus pregnancies are completely normal, 25% deliver normal babies prematurely, and spontaneous abortion (miscarriage) or death of the baby accounts for the rerighting 25%.
Pregnancy is advised against during flares as well as when major organ involvment is present.

Women conceiving after 5 or 6 months of remission are much less likely to experience lupus flares during her pregnancy than are those women who get pregnant while their lupus is active.
Lupus nephritis before conception also increases the chance of experiencing a lupus flare during pregnancy.

Women in remission have much less trouble than do women with active disease and their babies do much better also.
Aspirin is safe and it is most often used to protect against a complication known as toxemia of pregnancy.
Cyclophosphamide (Cytoxan) is definitely harmful if taken during the first three months of pregnancy.

Flares most often occur during the first or second trimester, or during the two months immediately after delivery.
The most common symptoms of flares during pregnancy are arthritis, rashes and fatigue.

Antibodies that interfere with the function of the placenta are called antiphospholidid antibodies.
These antibodies can occur during the second trimester, slowing the baby's growth.
Aspirin, Prednisone, Heparin, and Plasmapheresis have all been suggested as possible therapies for the antiphospholipid antibodies.

It is important to distinguish the symptoms of a lupus flare from the normal body changes that occur during pregnancy.

Frequent doctor visits are important in any high risk pregnancy because many conditions which may occur can be prevented or treated more easily when found early.

Prednisone does not get through the placenta and is safe for the baby.

Specifically, dexamethasone and betamethasone do reach the baby and are used only when it is necessary to treat the baby as well.

A few doctors feel that all pregnant women with lupus should take small doses of Prednisone to prevent early abortion.
Similarly, some physicians feel steroids should be given or increased after the baby is born to prevent post-partum flare.

It is important to note that although many lupus pregnancies will be completely normal,
all lupus pregnancies should be considered high-risk.
High-risk is a term commonly used by obstetricians to indicate that solvable problems may occur and should be anticipated.
Pregnant lupus patients should be managed by obstetricians who are thoroughly familiar with high risk pregnancies and work in close concert with the woman's other physicians.
Patients with Lupus and Sjogren&rsquos syndrome who plan to become pregnant should consult with their doctor about being tested for specific auto-antibodies (ANAs) that may be present in their blood.
These antibodies, anti-Ro (SS-A) and anti-La (SS-B), in rare cases, have been associated with heart problems in newborns, termed neonatal lupus syndrome.

When NEONATAL LUPUS Occurs:

Neonatal lupus is not SLE in babies
.

Neonatal lupus is the only type of congenital abnormality found in children of mothers who have lupus and it can also cause a rash on the infant which clears up within a few months.
About 3% of all pregnant lupus women will have a baby with a syndrome known as neonatal lupus.

Neonatal lupus consists of a transient rash, transient blood count abnormalities, and a special type of heart beat abnormality which is very rare and which is called heart block.
If the heart beat abnormality occurs, it is treatable although it is permanent.

For babies with neonatal lupus who do not have the heart problem, there is no trace of the disease by 6 months of age and it does not recur nor does it predispose the child to lupus later in life.
Even babies with the heart beat abnormality problem (heart block), have normal growth and development, living normal lives.


BACK

VASCULITIS

Vasculitis is an inflammation of the blood vessels.
Inflammation is a condition in which tissue is damaged by blood cells entering the tissues.
These are mostly white blood cells which circulate and serve as our major defense against infection.
Ordinarily, white blood cells destroy bacteria and viruses.
However, they can also damage normal tissue if they invade it.
Vasculitis can affect very small blood vessels (capillaries), medium-size blood vessels (arterioles or venules), or large blood vessels (arteries and veins).

Several things can happen to an inflamed blood vessel.
If it is a small vessel, it may bread and produce tiny areas of bleeding in the tissue.
These areas will appear as small red or purple dots on the skin.
If a larger vessel is inflamed, it may swell and produce a nodule which may be felt if the blood vessel is close to the skin surface.
The inside of the vessel tube may become narrowed so that blood flow is reduced, or the inside may become totally closed (usually by a blood clot which forms at the site of inflammation).

If blood flow is reduced or stopped, the tissues which receive blood from that vessel begin to die
Substances which cause allergic relations are called "antigens."
They cause the body to make proteins called "antibodies" which bind to the antigen for the purpose of getting rid of it.
Antigen and antibody bound together are called "immune complexes."

Two primary ways in which immune complexes destroy antigens are
by attracting white blood cells to digest the antigen, and
by activating other body substances to help destroy the antigens.

Unfortunately, some immune complexes do not serve their purpose of destroying antigens.
Instead, they reright too long in the body and circulate in the blood and deposit in tissues.
They commonly accumulate in blood vessel walls, where they cause inflammation.
It is likely that some white blood cells which kill infectious agents (cytotoxic cells) can also accidentally damage blood vessels and cause vasculitis.
In the vasculitis caused by lupus, the antigens causing the immune complexes are often not known.
In some cases, the complexes contain DNA and anti-DNA antigens, or Ro (also called SS-A) and anti-Ro antigens.
A recently discovered antibody, ANCA (anti-neutrophil cytoplasm antibody), can cause vasculitis in some individuals.

The diagnosis of vasculitis is based on a person's medical history, current symptoms, a complete physical examination, and the results of specialized laboratory tests.
Blood abnormalities which often occur when vasculitis is present include an elevated sedimentation rate, anemia, a high white blood count and a high platelet count.
Blood tests can also be used to identify immune complexes or antibodies that cause vasculitis in the circulation and measure whether complement levels are abnormal.
These tests take several days to complete.
The physician may also order a urine analysis.

If there are any symptoms that suggest heart involvement, tests that may be ordered include: EKG, ECHO cardiogram and heart scans.
For lung symptoms, the physician may order a chest x-ray, obtain blood from an artery to measure the oxygen content and blood gases, and schedule a pulmonary function test.
A pulmonary function test uses a specialized machine to measure how well the lungs handle air and oxygen as you breathe into it.
If there are abdominal symptoms, the physician may order ultrasound or CAT scans of the organs in the abdomen, or other special x-rays to see the intestines.
For brain symptoms, CAT scans and magnetic resonance images are frequently useful.
Many cases of vasculitis do not require treatment.
For example, a few spots on the skin now and then (if not combined with other symptoms) may not require any medications.
Most physicians recommend cortisone-type medications, such as Prednisone, Prednisolone, or methylprednisolone (Medrol) as the initial treatment for vasculitis.
Some people with severe vasculitis or vasculitis that does not respond well to cortisone-type drugs will need to be treated with cytotoxic drugs.
These medications kill the cells that cause inflammation in the blood vessels.
For the vast majority of people with vasculitis, treatment is very effective and prognosis is good.
The vasculitis may disappear only to reoccur later and require treatment again; or it may be suppressed but never really go away, so that some ongoing treatment is always required as with lupus.

BACK